Heritage Bio Labs
Research Library
Explore 411 articles about peptides, research compounds and related topics, with links to the original studies.
Find articles
All articles
Showing 61–72 of 411 articles
- Understand the science
What frozen receptor images show about cagrilintide
Cagrilintide is a long-acting peptide based on amylin, a hormone associated with signals after eating. For the specific question of how the peptide sits in its receptors, the older direct evidence comes from a 2025 study that visualized cagrilintide bound to several versions of the receptor family.
Cagrilintide1 source (2025)
- Check methods and identity
Which molecule does the name CJC-1295 No DAC describe?
CJC-1295 No DAC is commonly used as a label for modified growth hormone–releasing factor (1–29), or Mod GRF (1–29). The first question about a paper or catalog entry is whether that name refers to the same molecule in both places.
CJC-1295 No DAC1 source (2024)
- Interpret the evidence
What the growth hormone–releasing hormone receptor can tell us
CJC-1295 No DAC commonly refers to Mod GRF (1–29), a synthetic 29-residue relative of growth hormone–releasing hormone (GHRH) with four substitutions. Its design raises a specific question about how the original hormone engages its receptor.
CJC-1295 No DAC2 sources (2020, 2024)
- Understand the science
How a change near one end can affect peptide breakdown
CJC-1295 No DAC generally denotes Mod GRF (1–29), a growth hormone–releasing hormone (GHRH) fragment with four substitutions and no albumin-binding attachment. One of those substitutions helps frame a question about how researchers study peptide stability.
CJC-1295 No DAC2 sources (1989, 2024)
- Check methods and identity
What a growth hormone pulse measures
CJC-1295 No DAC is a catalog name commonly used for a four-substitution relative of the first 29 residues of growth hormone–releasing hormone (GHRH). What would a study have to measure to show how this compound affects the timing of growth hormone release?
CJC-1295 No DAC2 sources (1999, 2024)
- Understand the science
How a laboratory identified a no-DAC sequence in an unknown sample
CJC-1295 No DAC commonly names Mod GRF (1–29), an engineered version of the first 29 amino acids of growth hormone–releasing hormone (GHRH). How can a laboratory establish that an unknown preparation contains a peptide consistent with that description?
CJC-1295 No DAC2 sources (2010, 2024)
- Understand the science
From a growth hormone signal to an outcome in people
CJC-1295 No DAC generally refers to Mod GRF (1–29), a 29-residue analogue designed around the natural signal for growth hormone release. An important research question is how a hormone measurement could be connected to an outcome that matters to people with growth hormone deficiency.
CJC-1295 No DAC1 source (2024)
- Check methods and identity
What a 2026 horse-plasma test detected
CJC-1295 With DAC is a synthetic analogue of growth hormone–releasing hormone (GHRH) with a drug affinity complex that can form covalent bonds with blood proteins. That attachment raises an analytical question about what a laboratory needs to detect.
CJC-1295 With DAC2 sources (2024, 2026)
- Understand the science
How long did growth hormone and IGF-1 change in early human trials?
CJC-1295 With DAC is an investigational form of a growth hormone–releasing hormone (GHRH) analogue. Its attached drug affinity complex (DAC) allows it to bind to blood proteins. Early studies asked how long the circulating peptide and its effects could be measured in healthy adults.
CJC-1295 With DAC2 sources (2005, 2024)
- Interpret the evidence
The difference between growth hormone peaks and troughs
CJC-1295 With DAC is a growth hormone–releasing hormone (GHRH) analogue that attaches to proteins in the blood, extending exposure. A human experiment asked whether sustained stimulation would change the timing or the size of growth hormone pulses.
CJC-1295 With DAC2 sources (2006, 2024)
- Understand the science
What the original albumin-binding experiments established
CJC-1295 With DAC is an engineered form of growth hormone–releasing factor (GRF), also called growth hormone–releasing hormone. Its drug affinity complex (DAC) was designed to react with the blood protein albumin. The original 2005 development study provides older direct evidence for that design.
CJC-1295 With DAC2 sources (2005, 2026)
- Explore study findings
What an exploratory blood-protein study can establish
CJC-1295 With DAC is an engineered growth hormone–releasing hormone (GHRH) analogue that links to blood proteins. Researchers have used it in human experiments to perturb the growth hormone pathway and look for measurable changes farther downstream.
CJC-1295 With DAC2 sources (2009, 2024)
Browse by product
- A4 Amyloid Beta6 articles
- ACE-0316 articles
- ACE-0836 articles
- Adipotide6 articles
- AICAR6 articles
- AOD-96046 articles
- ARA-2906 articles
- BPC-1576 articles
- BPC-157 / TB-5006 articles
- Cagrilintide7 articles
- CJC-1295 (No DAC) / GHRP-26 articles
- CJC-1295 (No DAC) / GHRP-66 articles
- CJC-1295 (No DAC) / Ipamorelin6 articles
- CJC-1295 No DAC6 articles
- CJC-1295 With DAC6 articles
- DSIP6 articles
- Epitalon6 articles
- Follistatin 3156 articles
- Follistatin 3446 articles
- Fragment 176-1916 articles
- GHK-Cu6 articles
- GHRP-26 articles
- GHRP-66 articles
- GLOW 2 Blend6 articles
- GLOW Blend6 articles
- GLP-1 SEMA6 articles
- GLP-2 TIRZ6 articles
- Glutathione6 articles
- HCG6 articles
- Hexarelin6 articles
- Human Relaxin-26 articles
- IGF-1 DES 1,36 articles
- IGF-1 Human6 articles
- IGF-2 LR36 articles
- IGF-DES 1,36 articles
- IGF-LR36 articles
- Ipamorelin6 articles
- Kisspeptin-106 articles
- KLOW Blend6 articles
- KPV6 articles
- Lipopeptide6 articles
- Liraglutide6 articles
- Melanotan II5 articles
- MGF6 articles
- MOTS-C6 articles
- MSC Exosomes6 articles
- Myostatin6 articles
- Myostatin HMP (GDF8)6 articles
- Oxytocin7 articles
- PEG-MGF6 articles
- Pinealon6 articles
- PT-1416 articles
- RETA / IGF-1 LR36 articles
- RETA GLP-36 articles
- Selank6 articles
- SEMA / IGF-1 LR36 articles
- Semax6 articles
- Sermorelin6 articles
- SLU-PP-3326 articles
- SNAP-86 articles
- Survodutide7 articles
- TB-5006 articles
- Tesamorelin6 articles
- Thymosin Alpha-16 articles
- TIRZ / IGF-1 LR36 articles
- TIRZ GLP-26 articles
- Trevogrumab6 articles
- Triptorelin GnRH6 articles
